Annual report
9438.TEDINET S100SJ85
Period2022-10-01 → 2023-09-30
Filed2023-12-25
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Amended by S100SUQU (2024-02-14).
Key figures · 153
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥26.8bn | 2022-10-01 → 2023-09-30 | Cons. | Net sales |
| Revenue | ¥26.5bn | 2021-10-01 → 2022-09-30 | Cons. | Net sales |
| Revenue | ¥25.7bn | 2020-10-01 → 2021-09-30d | Cons. | Net sales (5-year summary) |
| Revenue | ¥26.1bn | 2019-10-01 → 2020-09-30d | Cons. | Net sales (5-year summary) |
| Revenue | ¥27.1bn | 2018-10-01 → 2019-09-30d | Cons. | Net sales (5-year summary) |
| Operating income | ¥298m | 2022-10-01 → 2023-09-30 | Cons. | Operating income |
| Operating income | ¥871m | 2021-10-01 → 2022-09-30 | Cons. | Operating income |
| Ordinary income | ¥458m | 2022-10-01 → 2023-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥486m | 2021-10-01 → 2022-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥1.4bn | 2020-10-01 → 2021-09-30d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.1bn | 2019-10-01 → 2020-09-30d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥3.1bn | 2018-10-01 → 2019-09-30d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥1.2bn | 2022-10-01 → 2023-09-30 | Cons. | Income before income taxes |
| Profit before tax | −¥305m | 2021-10-01 → 2022-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥753m | 2022-10-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥930m | 2021-10-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥1.2bn | 2020-10-01 → 2021-09-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥507m | 2019-10-01 → 2020-09-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.5bn | 2018-10-01 → 2019-09-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥568m | 2022-10-01 → 2023-09-30 | Cons. | Profit loss |
| Net income | −¥1.1bn | 2021-10-01 → 2022-09-30 | Cons. | Profit loss |
| Total assets | ¥29.2bn | at 2023-09-30 | Cons. | Assets |
| Total assets | ¥29.3bn | at 2022-09-30 | Cons. | Assets |
| Total assets | ¥31.9bn | at 2021-09-30d | Cons. | Total assets (5-year summary) |
| Total assets | ¥30.5bn | at 2020-09-30d | Cons. | Total assets (5-year summary) |
| Total assets | ¥27.5bn | at 2019-09-30d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥11.6bn | at 2023-09-30 | Cons. | Liabilities |
| Total liabilities | ¥11.4bn | at 2022-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥17.6bn | at 2023-09-30 | Cons. | Net assets |
| Net assets / equity | ¥17.9bn | at 2022-09-30 | Cons. | Net assets |
| Net assets / equity | ¥21.2bn | at 2021-09-30d | Cons. | Net assets |
| Net assets / equity | ¥21.5bn | at 2020-09-30d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥21.8bn | at 2019-09-30d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥13.7bn | at 2023-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥12.1bn | at 2022-09-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥13.7bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥12.1bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥15.5bn | at 2021-09-30d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥13.4bn | at 2020-09-30d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥12.4bn | at 2019-09-30d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥4.8bn | 2022-10-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥1.4bn | 2021-10-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥3.5bn | 2020-10-01 → 2021-09-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥3.3bn | 2019-10-01 → 2020-09-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥4.0bn | 2018-10-01 → 2019-09-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥1.3bn | 2022-10-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.5bn | 2021-10-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.0bn | 2020-10-01 → 2021-09-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥4.8bn | 2019-10-01 → 2020-09-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥3.6bn | 2018-10-01 → 2019-09-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥1.8bn | 2022-10-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥344m | 2021-10-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥649m | 2020-10-01 → 2021-09-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥2.4bn | 2019-10-01 → 2020-09-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥1.5bn | 2018-10-01 → 2019-09-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥13.73 | 2022-10-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-16.99 | 2021-10-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-21.28 | 2020-10-01 → 2021-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥9.28 | 2019-10-01 → 2020-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥27.59 | 2018-10-01 → 2019-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥9.27 | 2019-10-01 → 2020-09-30d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥27.56 | 2018-10-01 → 2019-09-30d | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥254.36 | at 2023-09-30 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥256.61 | at 2022-09-30 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥318.29 | at 2021-09-30d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥350.83 | at 2020-09-30d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥363.53 | at 2019-09-30d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 47.9% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 48.1% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 54.6% | at 2021-09-30d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 62.7% | at 2020-09-30d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 72.3% | at 2019-09-30d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 5.4% | 2022-10-01 → 2023-09-30 | Cons. | Rate of return on equity (5-year summary) |
| ROE | -5.9% | 2021-10-01 → 2022-09-30 | Cons. | Rate of return on equity (5-year summary) |
| ROE | -6.4% | 2020-10-01 → 2021-09-30d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 2.6% | 2019-10-01 → 2020-09-30d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 8.0% | 2018-10-01 → 2019-09-30d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 1,202 | at 2023-09-30 | Cons. | Number of employees |
| Employees | 1,316 | at 2022-09-30 | Cons. | Number of employees |
| Employees | 1,295 | at 2021-09-30d | Cons. | Number of employees |
| Employees | 1,194 | at 2020-09-30d | Cons. | Number of employees |
| Employees | 1,136 | at 2019-09-30d | Cons. | Number of employees |
| Revenue | ¥20.8bn | 2022-10-01 → 2023-09-30 | Standalone | Net sales |
| Revenue | ¥21.4bn | 2021-10-01 → 2022-09-30 | Standalone | Net sales |
| Revenue | ¥20.7bn | 2020-10-01 → 2021-09-30d | Standalone | Net sales (5-year summary) |
| Revenue | ¥20.9bn | 2019-10-01 → 2020-09-30d | Standalone | Net sales (5-year summary) |
| Revenue | ¥21.8bn | 2018-10-01 → 2019-09-30d | Standalone | Net sales (5-year summary) |
| Operating income | ¥1.5bn | 2022-10-01 → 2023-09-30 | Standalone | Operating income |
| Operating income | ¥2.9bn | 2021-10-01 → 2022-09-30 | Standalone | Operating income |
| Ordinary income | ¥762m | 2022-10-01 → 2023-09-30 | Standalone | Ordinary income |
| Ordinary income | ¥1.3bn | 2021-10-01 → 2022-09-30 | Standalone | Ordinary income |
| Ordinary income | ¥2.3bn | 2020-10-01 → 2021-09-30d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥3.5bn | 2019-10-01 → 2020-09-30d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.8bn | 2018-10-01 → 2019-09-30d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥2.7bn | 2022-10-01 → 2023-09-30 | Standalone | Income before income taxes |
| Profit before tax | −¥3.2bn | 2021-10-01 → 2022-09-30 | Standalone | Income before income taxes |
| Net income | ¥2.4bn | 2022-10-01 → 2023-09-30 | Standalone | Profit loss |
| Net income | −¥3.5bn | 2021-10-01 → 2022-09-30 | Standalone | Profit loss |
| Net income | ¥5.0bn | 2020-10-01 → 2021-09-30d | Standalone | Net income loss (5-year summary) |
| Net income | ¥1.0bn | 2019-10-01 → 2020-09-30d | Standalone | Net income loss (5-year summary) |
| Net income | ¥12m | 2018-10-01 → 2019-09-30d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥26.8bn | at 2023-09-30 | Standalone | Assets |
| Total assets | ¥25.0bn | at 2022-09-30 | Standalone | Assets |
| Total assets | ¥30.3bn | at 2021-09-30d | Standalone | Total assets (5-year summary) |
| Total assets | ¥24.8bn | at 2020-09-30d | Standalone | Total assets (5-year summary) |
| Total assets | ¥21.5bn | at 2019-09-30d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥10.3bn | at 2023-09-30 | Standalone | Liabilities |
| Total liabilities | ¥10.0bn | at 2022-09-30 | Standalone | Liabilities |
| Net assets / equity | ¥16.5bn | at 2023-09-30 | Standalone | Net assets |
| Net assets / equity | ¥15.0bn | at 2022-09-30 | Standalone | Net assets |
| Net assets / equity | ¥20.9bn | at 2021-09-30d | Standalone | Net assets |
| Net assets / equity | ¥16.6bn | at 2020-09-30d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥16.8bn | at 2019-09-30d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥9.8bn | at 2023-09-30 | Standalone | Cash and deposits |
| Cash and deposits | ¥6.5bn | at 2022-09-30 | Standalone | Cash and deposits |
| EPS (basic) | ¥43.69 | 2022-10-01 → 2023-09-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-64.1 | 2021-10-01 → 2022-09-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥90.56 | 2020-10-01 → 2021-09-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥18.43 | 2019-10-01 → 2020-09-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥0.21 | 2018-10-01 → 2019-09-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥90.26 | 2020-10-01 → 2021-09-30d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥18.42 | 2019-10-01 → 2020-09-30d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥0.21 | 2018-10-01 → 2019-09-30d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥16 | 2022-10-01 → 2023-09-30 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥16 | 2021-10-01 → 2022-09-30 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥16 | 2020-10-01 → 2021-09-30d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥16 | 2019-10-01 → 2020-09-30d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥16 | 2018-10-01 → 2019-09-30d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥299.51 | at 2023-09-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥271.45 | at 2022-09-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥377.02 | at 2021-09-30d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥299.23 | at 2020-09-30d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥301.78 | at 2019-09-30d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 61.5% | at 2023-09-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 59.6% | at 2022-09-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 68.3% | at 2021-09-30d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 66.1% | at 2020-09-30d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 76.8% | at 2019-09-30d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 15.3% | 2022-10-01 → 2023-09-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | -19.8% | 2021-10-01 → 2022-09-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 26.8% | 2020-10-01 → 2021-09-30d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.1% | 2019-10-01 → 2020-09-30d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 0.1% | 2018-10-01 → 2019-09-30d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 61,264,600 | at 2023-09-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 61,263,000 | at 2022-09-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 61,248,200 | at 2021-09-30d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 61,144,600 | at 2020-09-30d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 61,139,000 | at 2019-09-30d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 750 | at 2023-09-30 | Standalone | Number of employees |
| Employees | 762 | at 2022-09-30 | Standalone | Number of employees |
| Employees | 757 | at 2021-09-30d | Standalone | Number of employees |
| Employees | 734 | at 2020-09-30d | Standalone | Number of employees |
| Employees | 716 | at 2019-09-30d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 56
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | depreciation | 2022-10-01 → 2023-09-30 | ¥75m |
| Reconciling Itemsreconciling | revenue | 2022-10-01 → 2023-09-30 | −¥1.6bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-10-01 → 2023-09-30 | −¥1.6bn |
| Reconciling Itemsreconciling | segment profit | 2022-10-01 → 2023-09-30 | −¥2.6bn |
| Content Businessreportable segment | depreciation | 2022-10-01 → 2023-09-30 | ¥860m |
| Content Businessreportable segment | revenue | 2022-10-01 → 2023-09-30 | ¥18.1bn |
| Content Businessreportable segment | revenue external | 2022-10-01 → 2023-09-30 | ¥17.9bn |
| Content Businessreportable segment | revenue intersegment | 2022-10-01 → 2023-09-30 | ¥164m |
| Content Businessreportable segment | segment profit | 2022-10-01 → 2023-09-30 | ¥5.2bn |
| Healthcare Businessreportable segment | depreciation | 2022-10-01 → 2023-09-30 | ¥241m |
| Healthcare Businessreportable segment | revenue | 2022-10-01 → 2023-09-30 | ¥4.6bn |
| Healthcare Businessreportable segment | revenue external | 2022-10-01 → 2023-09-30 | ¥4.6bn |
| Healthcare Businessreportable segment | revenue intersegment | 2022-10-01 → 2023-09-30 | ¥10m |
| Healthcare Businessreportable segment | segment profit | 2022-10-01 → 2023-09-30 | −¥225m |
| Other Businessreportable segment | depreciation | 2022-10-01 → 2023-09-30 | ¥45m |
| Other Businessreportable segment | revenue | 2022-10-01 → 2023-09-30 | ¥4.8bn |
| Other Businessreportable segment | revenue external | 2022-10-01 → 2023-09-30 | ¥3.4bn |
| Other Businessreportable segment | revenue intersegment | 2022-10-01 → 2023-09-30 | ¥1.4bn |
| Other Businessreportable segment | segment profit | 2022-10-01 → 2023-09-30 | −¥1.4bn |
| School DX Businessreportable segment | depreciation | 2022-10-01 → 2023-09-30 | ¥208m |
| School DX Businessreportable segment | revenue | 2022-10-01 → 2023-09-30 | ¥852m |
| School DX Businessreportable segment | revenue external | 2022-10-01 → 2023-09-30 | ¥852m |
| School DX Businessreportable segment | segment profit | 2022-10-01 → 2023-09-30 | −¥668m |
| —segment total | depreciation | 2022-10-01 → 2023-09-30 | ¥1.4bn |
| —segment total | revenue | 2022-10-01 → 2023-09-30 | ¥28.4bn |
| —segment total | revenue external | 2022-10-01 → 2023-09-30 | ¥26.8bn |
| —segment total | revenue intersegment | 2022-10-01 → 2023-09-30 | ¥1.6bn |
| —segment total | segment profit | 2022-10-01 → 2023-09-30 | ¥2.9bn |
| Reconciling Itemsreconciling | depreciation | 2021-10-01 → 2022-09-30 | ¥101m |
| Reconciling Itemsreconciling | revenue | 2021-10-01 → 2022-09-30 | −¥1.3bn |
| Reconciling Itemsreconciling | revenue intersegment | 2021-10-01 → 2022-09-30 | −¥1.3bn |
| Reconciling Itemsreconciling | segment profit | 2021-10-01 → 2022-09-30 | −¥2.6bn |
| Content Businessreportable segment | depreciation | 2021-10-01 → 2022-09-30 | ¥906m |
| Content Businessreportable segment | revenue | 2021-10-01 → 2022-09-30 | ¥18.5bn |
| Content Businessreportable segment | revenue external | 2021-10-01 → 2022-09-30 | ¥18.3bn |
| Content Businessreportable segment | revenue intersegment | 2021-10-01 → 2022-09-30 | ¥234m |
| Content Businessreportable segment | segment profit | 2021-10-01 → 2022-09-30 | ¥6.2bn |
| Healthcare Businessreportable segment | depreciation | 2021-10-01 → 2022-09-30 | ¥210m |
| Healthcare Businessreportable segment | revenue | 2021-10-01 → 2022-09-30 | ¥4.0bn |
| Healthcare Businessreportable segment | revenue external | 2021-10-01 → 2022-09-30 | ¥4.0bn |
| Healthcare Businessreportable segment | revenue intersegment | 2021-10-01 → 2022-09-30 | ¥16m |
| Healthcare Businessreportable segment | segment profit | 2021-10-01 → 2022-09-30 | −¥1.1bn |
| Other Businessreportable segment | depreciation | 2021-10-01 → 2022-09-30 | ¥113m |
| Other Businessreportable segment | revenue | 2021-10-01 → 2022-09-30 | ¥4.8bn |
| Other Businessreportable segment | revenue external | 2021-10-01 → 2022-09-30 | ¥3.8bn |
| Other Businessreportable segment | revenue intersegment | 2021-10-01 → 2022-09-30 | ¥1.1bn |
| Other Businessreportable segment | segment profit | 2021-10-01 → 2022-09-30 | −¥826m |
| School DX Businessreportable segment | depreciation | 2021-10-01 → 2022-09-30 | ¥164m |
| School DX Businessreportable segment | revenue | 2021-10-01 → 2022-09-30 | ¥426m |
| School DX Businessreportable segment | revenue external | 2021-10-01 → 2022-09-30 | ¥426m |
| School DX Businessreportable segment | segment profit | 2021-10-01 → 2022-09-30 | −¥841m |
| —segment total | depreciation | 2021-10-01 → 2022-09-30 | ¥1.4bn |
| —segment total | revenue | 2021-10-01 → 2022-09-30 | ¥27.8bn |
| —segment total | revenue external | 2021-10-01 → 2022-09-30 | ¥26.5bn |
| —segment total | revenue intersegment | 2021-10-01 → 2022-09-30 | ¥1.3bn |
| —segment total | segment profit | 2021-10-01 → 2022-09-30 | ¥3.4bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,738
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of shares issued shares voting rights | CurrentYearInstant_OrdinarySharesReciprocalHoldingSharesWithFullVotingRightsTreasurySharesEtcMember | 672000 | |
| Number of voting rights issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 543802 | |
| Number of shares issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 54380200 | |
| Number of shares issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesLessThanOneUnitMember | 5700 | |
| Number of shares issued shares voting rights | CurrentYearInstant | 61264600 | |
| Number of voting rights issued shares voting rights | CurrentYearInstant | 543802 | |
| Number of shares held in own name treasury shares etc | CurrentYearInstant_Row1Member | 6206700 | |
| Number of shares held in others names treasury shares etc | CurrentYearInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | CurrentYearInstant_Row1Member | 6206700 | |
| Shareholding ratio treasury shares etc | CurrentYearInstant_Row1Member | 0.1013 | |
| Number of shares held in own name treasury shares etc | CurrentYearInstant_Row2Member | 672000 | |
| Number of shares held in others names treasury shares etc | CurrentYearInstant_Row2Member | － | |
| Total number of shares held treasury shares etc | CurrentYearInstant_Row2Member | 672000 | |
| Shareholding ratio treasury shares etc | CurrentYearInstant_Row2Member | 0.0110 | |
| Number of shares held in own name treasury shares etc | CurrentYearInstant | 6878700 | |
| Number of shares held in others names treasury shares etc | CurrentYearInstant | － | |
| Total number of shares held treasury shares etc | CurrentYearInstant | 6878700 | |
| Shareholding ratio treasury shares etc | CurrentYearInstant | 0.1123 | |
| Total amount of dividends dividends of surplus | FilingDateInstant_Row1Member | 440498000 | JPY |
| Dividend per share dividends of surplus | FilingDateInstant_Row1Member | 8 | |
| Total amount of dividends dividends of surplus | FilingDateInstant_Row2Member | 440462000 | JPY |
| Dividend per share dividends of surplus | FilingDateInstant_Row2Member | 8 | |
| Number of male directors and other officers | FilingDateInstant | 11 | |
| Number of female directors and other officers | FilingDateInstant | 3 | |
| Ratio of female directors and other officers | FilingDateInstant | 0.21 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E05049-000MaetaToshihiroMember | 11875700 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E05049-000IzumiHiroshiMember | 343800 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E05049-000MatsumotoHiroshiMember | 169400 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E05049-000IshikawaKouichiMember | 4700 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E05049-000MuzhiZhouMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E05049-000YamamotoHikaruMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E05049-000TsuchiyaRyosukeMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E05049-000FujitaSatoshiMember | 4000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E05049-000YokoyamaYoshinoriMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E05049-000WadaHideakiMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E05049-000NiwaYasuhikoMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E05049-000KasaharaChieMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E05049-000YasudaNarikiMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E05049-000OkudaTakakoMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant | 12416600 | |
| Audit fees reporting company | Prior1YearDuration | 49000000 | JPY |
| Non audit fees reporting company | Prior1YearDuration | － | JPY |
| Audit fees reporting company | CurrentYearDuration | 52000000 | JPY |
| Non audit fees reporting company | CurrentYearDuration | 12000000 | JPY |
| Audit fees consolidated subsidiaries | Prior1YearDuration | 12120000 | JPY |
| Non audit fees consolidated subsidiaries | Prior1YearDuration | － | JPY |
| Audit fees consolidated subsidiaries | CurrentYearDuration | 10440000 | JPY |
| Non audit fees consolidated subsidiaries | CurrentYearDuration | － | JPY |
| Audit fees total | Prior1YearDuration | 61120000 | JPY |
| Non audit fees total | Prior1YearDuration | － | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |